GeneLink, Inc.
GNLKQ
$0.00
$0.000.00%
| 09/30/2013 | 06/30/2013 | ||||
|---|---|---|---|---|---|
| Revenue | -52.61% | 55.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -52.61% | 55.51% | |||
| Cost of Revenue | -28.99% | 1.76% | |||
| Gross Profit | -76.54% | 234.42% | |||
| SG&A Expenses | 24.29% | 21.54% | |||
| Depreciation & Amortization | -2.27% | -9.59% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.16% | 13.85% | |||
| Operating Income | -151.06% | 32.76% | |||
| Income Before Tax | -65.89% | 8.11% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -65.89% | 8.11% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -65.89% | 8.11% | |||
| EBIT | -151.06% | 32.76% | |||
| EBITDA | -165.71% | 33.96% | |||
| EPS Basic | -53.85% | 7.14% | |||
| Normalized Basic EPS | -100.00% | 27.27% | |||
| EPS Diluted | -53.85% | 7.14% | |||
| Normalized Diluted EPS | -100.00% | 27.27% | |||
| Average Basic Shares Outstanding | 2.15% | 1.75% | |||
| Average Diluted Shares Outstanding | 2.15% | 1.75% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
